Related references
Note: Only part of the references are listed.Evaluation of favipiravir in the treatment of COVID-19 based on the real-world
Weishang Deng et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2022)
Future of antivirals in COVID-19: The case of favipiravir
Chia Siang Kow et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
A novel stability-indicating HPLC-DAD method for determination of favipiravir, a potential antiviral drug for COVID-19 treatment; application to degradation kinetic studies and in-vitro dissolution profiling
Hoda M. Marzouk et al.
MICROCHEMICAL JOURNAL (2022)
The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies
Serdar Durdagi et al.
MOLECULAR THERAPY (2022)
Favipiravir (SARS-CoV-2) degradation impurities: Identification and route of degradation mechanism in the finished solid dosage form using LC/LC-MS method
Divya Kumar Vemuri et al.
BIOMEDICAL CHROMATOGRAPHY (2022)
Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2
Neslihan Pakize Tasli et al.
FRONTIERS IN IMMUNOLOGY (2022)
Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development
Yuefei Zhu et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Role of favipiravir in the treatment of COVID-19
Shashank Joshi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial
Zarir F. Udwadia et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Causes of death and comorbidities in hospitalized patients with COVID-19
Sefer Elezkurtaj et al.
SCIENTIFIC REPORTS (2021)
Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis
Ahmad Alamer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2021)
Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial
Mustafa Erelel et al.
PHARMACEUTICS (2021)
The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
Soheil Hassanipour et al.
SCIENTIFIC REPORTS (2021)
Favipiravir versus standard of care in patients with severe COVID-19 infections: A retrospective comparative study
Zainab Almoosa et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)
Favipiravir and COVID-19: A Simplified Summary
Morteza Ghasemnejad-Berenji et al.
DRUG RESEARCH (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
Kimiyasu Shiraki et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Sangeun Jeon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Lung tissue distribution of drugs as a key factor for COVID-19 treatment
Yan Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Transmission of coronavirus by nebulizer: a serious, underappreciated risk
Israel Amirav et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)
Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection
Du Yin-Xiao et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
In Vitro and Animal Models for SARS-CoV-2 research
Kazuo Takayama
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
The proximal origin of SARS-CoV-2
Kristian G. Andersen et al.
NATURE MEDICINE (2020)
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review
W. Joost Wiersinga et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Seth J. Zost et al.
NATURE MEDICINE (2020)
Identifying airborne transmission as the dominant route for the spread of COVID-19
Renyi Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Promoting safe and effective use of aerosol devices in COVID-19: risks and suggestions for viral transmission
Arzu Ari
EXPERT OPINION ON DRUG DELIVERY (2020)
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis
Ashleigh Shannon et al.
NATURE COMMUNICATIONS (2020)
Lung Deposition Using the Respimat(R) Soft Mist™ Inhaler Mono and Fixed-Dose Combination Therapies: An In Vitro/In Silico Analysis
Anna-Maria Ciciliani et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2020)
Robust real-time cell analysis method for determining viral infectious titers during development of a viral vaccine production process
Cedric Charretier et al.
JOURNAL OF VIROLOGICAL METHODS (2018)
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
Yousuke Furuta et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)
Higher lung deposition with Respimat® Soft Mist™ Inhaler than HFA-MDI in COPD patients with poor technique
Anja Schulze
International Journal of Chronic Obstructive Pulmonary Disease (2016)
Evaluation of 36 formulas for calculating plasma osmolality
Andreas S. Fazekas et al.
INTENSIVE CARE MEDICINE (2013)
Real-time cell analysis - A new method for dynamic, quantitative measurement of infectious viruses and antiserum neutralizing activity
Zheng Teng et al.
JOURNAL OF VIROLOGICAL METHODS (2013)
Real-time monitoring of flavivirus induced cytopathogenesis using cell electric impedance technology
Ying Fang et al.
JOURNAL OF VIROLOGICAL METHODS (2011)
Formulation strategy and use of excipients in pulmonary drug delivery
Gabrielle Pilcer et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Mechanisms of acid and base secretion by the airway epithelium
Horst Fischer et al.
JOURNAL OF MEMBRANE BIOLOGY (2006)
Deposition of corticosteroid aerosol in the human lung by Respimat® Soft Mist™ Inhaler compared to deposition by metered dose inhaler or by Turbuhaler® dry powder inhaler
G Pitcairn et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2005)
Metabolism and disposition of the HIV-1 protease inhibitor lopinavir (ABT-378) given in combination with ritonavir in rats, dogs, and humans
GN Kumar et al.
PHARMACEUTICAL RESEARCH (2004)